Skorpios Trust 13D and 13G filings for Akero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-09-12 4:30 pm Sale | 2023-09-08 | 13G | Akero Therapeutics, Inc. AKRO | Skorpios Trust | 0 0.000% | -3,271,829 (Position Closed) | Filing |
| 2022-12-05 4:40 pm Sale | 2022-12-01 | 13G | Akero Therapeutics, Inc. AKRO | Skorpios Trust | 3,271,829 7.000% | -1,636,000 (-33.33%) | Filing |
| 2021-06-30 4:17 pm Purchase | 2021-06-21 | 13G | Akero Therapeutics, Inc. AKRO | Skorpios Trust | 4,907,829 14.100% | 4,907,829 (New Position) | Filing |